H.R. 7902 · 119th Congress (2025–2027)
Safeguarding Women from Chemical Abortion Act
To provide that the approved application under the Federal Food, Drug, and Cosmetic Act for the drug mifepristone for the purpose of the termination of intrauterine pregnancy is deemed to have been withdrawn, to establish a Federal tort for harm to women caused by chemical abortion drugs, and for other purposes.
CRS summary not yet available.
Referred to committee
Latest actionReferred to committee
This bill’s path
This is H.R. 7902’s recorded path, not a universal congressional workflow.
How bills become lawAll actionsIntroduced
Passed House
Passed Senate
Sent to President
Signed into law
- Sponsor
- Rep. Diana Harshbarger (R-TN-1)
- Cosponsors
11 cosponsors
0 original · 11 later
11 R
- Rep. John W. Rose (R-TN-6)· Later · Mar 18, 2026
- Rep. Mark Alford (R-MO-4)· Later · Mar 20, 2026
- Rep. Neal P. Dunn (R-FL-2)· Later · Mar 20, 2026
- Rep. Sheri Biggs (R-SC-3)· Later · Mar 24, 2026
- Rep. Tracey Mann (R-KS-1)· Later · Mar 24, 2026
- Rep. Christopher H. Smith (R-NJ-4)· Later · Apr 22, 2026
- Rep. Mary E. Miller (R-IL-15)· Later · May 14, 2026
- Rep. W. Gregory Steube (R-FL-17)· Later · May 21, 2026
- Rep. Ralph Norman (R-SC-5)· Later · Aug 31, 2026
- Rep. Roger Williams (R-TX-25)· Later · Aug 31, 2026
- Rep. Andrew S. Clyde (R-GA-9)· Later · Sep 1, 2026
- Policy area
- Health
On this page
Timeline
i
In chronological order. Major procedural acts are shown in full. Committee work and ordinary amendments fold in place where they happened, so they do not jump the sequence or stretch the timeline.
Introduced in House
Document: Introduced in House
Sources
- Congress.gov actionIntro-H
- Library of Congress
- Latest
Referred to committee
Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Sources
- Congress.gov action
- House floor actions
Committees
Text & titles
i
Each distinct name Congress.gov recorded, once. Official, short, display, and popular titles stay distinct when the wording differs. The same wording is not repeated for every text version.
| Version | Date | Links |
|---|---|---|
| Introduced in House |
Titles (2)
Safeguarding Women from Chemical Abortion Act
Display title, Short title · Introduced in House
To provide that the approved application under the Federal Food, Drug, and Cosmetic Act for the drug mifepristone for the purpose of the termination of intrauterine pregnancy is deemed to have been withdrawn, to establish a Federal tort for harm to women caused by chemical abortion drugs, and for other purposes.
Official title · Introduced in House